Purchases and Sales Made in Q2 2021 in Monopar Therapeutics (MNPR)
This table provides information about the institutional ownership of Monopar Therapeutics (MNPR) during Q2 2021. The information is specifically focused on institutions that hold shares of Monopar Therapeutics.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 13, 2021
Q2 2021
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
97.5KNew |
$492K - $633K
|
97.5K
$4.73M
|
|
|
Aug 11, 2021
Q2 2021
|
Black Rock Inc.
New York, NY |
BUY
|
- |
15KNew |
$76K - $97.6K
|
15K
$730K
|
|
|
Aug 16, 2021
Q2 2021
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
5.13KNew |
$25.9K - $33.3K
|
5.13K
$249K
|
|
|
Aug 13, 2021
Q2 2021
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
2.37K+ 8.97% |
$12K - $15.4K
|
28.8K
$1.39M
|
|
|
Mar 22, 2023
Q2 2021
|
American Portfolios Advisors
Holbrook, NY |
BUY
|
- |
700New |
$3.54K - $4.54K
|
700
$34K
|
|
|
Aug 13, 2021
Q2 2021
|
Northern Trust Corp
Chicago, IL |
BUY
|
- |
105+ 0.29% |
$530 - $681
|
36.1K
$1.75M
|
|
|
Jul 12, 2021
Q2 2021
|
Paragon Wealth Strategies, LLC
|
BUY
|
- |
58New |
$293 - $376
|
58
$2.81K
|
|
|
Aug 16, 2021
Q2 2021
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
8+ 42.11% |
$40.4 - $51.9
|
27
$1.31K
|
|
|
Aug 13, 2021
Q2 2021
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Aug 13, 2021
Q2 2021
|
Ubs Group Ag
|
SELL
|
- |
-571Closed |
$2.88K - $3.71K
|
0
$0
|
|
|
Aug 16, 2021
Q2 2021
|
Tower Research Capital LLC (Trc)
New York, NY |
SELL
|
- |
-2.21KClosed |
$11.2K - $14.4K
|
0
$0
|
|
|
Aug 13, 2021
Q2 2021
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-47.7KClosed |
$241K - $309K
|
0
$0
|